Bipolar Disorder Clinical Trial
Official title:
CBT for Mood-Driven, Problematic, Impulsive Behaviours in Bipolar Disorder: A Case Series Evaluation
The goal of this case series is to explore whether a talking therapy, specifically Cognitive Behavioural Therapy (CBT) is acceptable and feasible in the management of mood-driven impulsive behaviours in people with bipolar disorder (BD). The main questions it aims to answer are: - Whether CBT Is a feasible intervention for participants with BD who report mood-driven, problematic impulsive behaviours. - Whether CBT for mood-driven, problematic impulsive behaviours (CBT-PIB) is acceptable to service users with BD and therapists. - Whether clinical outcomes are consistent with the potential for this novel intervention to offer clinical benefit to participants with BD. The study also hopes to: - conduct a preliminary examination of the safety of CBT-PIB and the research procedures. - gather information on the potential mechanisms of action of CBT-PIB and, - gather information on the types of mood-driven impulsive behaviours individuals with BD may seek support for. Participants will: - be offered up to 12 individual sessions of CBT focusing on mood-driven impulsive behaviours. - be asked to complete a battery of self-report measures (5) when they enter the study and at the start and end of treatment. - be asked to track mood and impulsive behaviours by completing a brief set of measures (3) weekly during the two-week baseline phase, the intervention phase and the 2-week post-intervention phase. - be asked to complete a survey on the acceptability of the intervention and - be invited to an optional semi-structured interview on their research experience.
Status | Recruiting |
Enrollment | 10 |
Est. completion date | June 24, 2024 |
Est. primary completion date | June 10, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - meeting diagnostic criteria for Bipolar I or II Disorder (SCID-5- Structured clinical interview for depression ) - able to identify at least one impulsive, problematic behaviour to target during the intervention; - participants will require working knowledge of written and spoken English, sufficient to be able to make use of therapy and to be able complete research assessments without the need of a translator. Exclusion Criteria: - major depressive episode (identified through SCID-DSM-5); - current experience of mania; - current/past learning disability (IQ of less than 70 with impairment of social and adaptive functioning) - organic brain change or substance dependence (drugs and alcohol) that would compromise ability to use therapy; - current marked risk to self (i.e. self-harm or suicide) that we deem could not be appropriately managed in by the therapy site; - currently lacking capacity to give informed consent; - currently receiving other psychosocial therapy for impulsivity or bipolar disorder; - current engagement in another psychological intervention addressing bipolar disorder or impulsivity; - presence of another area of difficulty that the therapist and client believe should be the primary focus of intervention (for example, Post-Traumatic Stress Disorder, psychosis). |
Country | Name | City | State |
---|---|---|---|
United Kingdom | AccEPT Clinic | Exeter | Devon |
Lead Sponsor | Collaborator |
---|---|
University of Exeter | Devon Partnership NHS Trust, Somerset NHS Foundation Trust, Southern Health NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall acceptability and feasibility of the CBT protocol measured by the Client Satisfaction Questionnaire CBT-PIB | qualitative and quantitative feedback from participants | Post-intervention at week 16 | |
Primary | rates of clinically significant and reliable change in mood measured by the Patient health questionnaire (PHQ-9) | used to monitor the severity of depression and response to treatment | Through study completion, an average of 18 weeks | |
Primary | rates of clinically significant and reliable change in symptoms of mania measured by the Altman Self-Rating Mania Scale | scale that assesses the presence and severity of manic or hypomanic symptoms | Through study completion, an average of 18 weeks | |
Primary | Changes in management of impulsivity measured by the Visual Analogue Scale | Visual scale measuring the severity and impact of general and behavioural impulsivity | Through study completion, an average of 18 weeks | |
Primary | Number of participants with intervention-related adverse events assessed by the adverse events form | qualitative form eliciting adverse events | Through study completion, an average of 18 weeks | |
Secondary | rates of clinically significant and reliable change in general daily functioning as measured by the Work and Social Adjustment Scale | scale assesses changes in the impact of a person's mental health difficulties on their ability to function in terms of work, home management, social leisure, private leisure and personal or family relationships. | At baseline, 2 weeks and 14 weeks | |
Secondary | rates of clinically significant and reliable change in quality of life as measured by the Brief Quality of Life in Bipolar Disorder | self-report measure of changes in disorder-specific quality of life | At baseline, 2 weeks and 14 weeks | |
Secondary | rates of clinically significant and reliable change in symptoms of anxiety as measured by the General Anxiety Disorder Assessment (GAD7) | scale measuring changes in symptoms of anxiety | At baseline, in 2 weeks and in 14 weeks | |
Secondary | rates of clinically significant and reliable change in overall wellbeing as measured by the Warwick-Edinburgh Mental Well-being Scale | scale measuring changes in positive features of mental health | At baseline, in 2 weeks and in 14 weeks | |
Secondary | rates of clinically significant and reliable change in impulsivity measured by the Short Urgency, Premeditation (lack of), Perseverance (lack of), Sensation Seeking, Positive Urgency, Impulsive Behavior Scale | Scale measuring changes in 5 domains of impulsive behaviour | At baseline, in 2 weeks and in 14 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 |